Bodei, L <br/><br/>
The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours.  [electronic resource] 

 -  European journal of nuclear medicine and molecular imaging  May 2013 
 - 800-16 p.  digital 
<br/><br/> Publication Type: Journal Article; Practice Guideline 
<br/><br/><label>ISSN: </label>1619-7089 
<br/><br/><label>Standard No.: </label>10.1007/s00259-012-2330-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Europe<br/>Follow-Up Studies<br/>Humans<br/>International Agencies<br/>Kidney--physiology<br/>Molecular Targeted Therapy--adverse effects<br/>Neuroendocrine Tumors--metabolism<br/>Nuclear Energy<br/>Quality Control<br/>Radiometry<br/>Radiopharmaceuticals--adverse effects<br/>Radiotherapy--adverse effects<br/>Receptors, Peptide--metabolism<br/>Societies, Scientific